Work

Ensuring the Appropriate Use of Glucagon‐Like Peptide‐1 Receptor Agonists

Year: 2024

Type: article

Abstract: Kenneth Todd Moore is an employee and stockholder of Janssen Pharmaceuticals. Parag Kumar is an employee and stockholder of Gilead Sciences. Aman Gupta discloses no conflicts of interest. Jinshan Shen is an employee and stockholder of Relay Therapeutics. This will not be Open Access.

Source: The Journal of Clinical Pharmacology

DOI: 10.1002/jcph.6136

Authors: Kenneth Todd Moore, Aman Gupta, Jinshan Shen, Parag Kumar

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $3,950

OpenAlex ID: W4402643741

FWCI:

Cites: 26

Cited by:

Related to: 10